Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) PT at $35.22

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $34.44.

Several brokerages recently issued reports on XRAY. The Goldman Sachs Group cut their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Piper Sandler restated a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating for the company in a research note on Tuesday, June 25th. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was bought at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.52% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Norges Bank acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at $114,207,000. Nuance Investments LLC increased its holdings in DENTSPLY SIRONA by 30.4% in the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares in the last quarter. Generation Investment Management LLP increased its holdings in DENTSPLY SIRONA by 43.4% in the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after buying an additional 1,998,012 shares in the last quarter. Wellington Management Group LLP increased its holdings in DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after buying an additional 1,419,503 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in DENTSPLY SIRONA by 2,959.1% in the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock valued at $45,584,000 after buying an additional 1,328,525 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $24.91 on Monday. The firm’s 50 day simple moving average is $27.72 and its 200-day simple moving average is $31.71. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a one year low of $24.71 and a one year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. DENTSPLY SIRONA’s revenue was down 2.6% compared to the same quarter last year. During the same period last year, the company posted $0.39 earnings per share. Analysts forecast that DENTSPLY SIRONA will post 2.02 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.57%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.